genetic engineering of phages

Cytophage Technologies Ltd. develops tailor-made bacteriophages as a sustainable solution to bacterial infection and disease. Using proprietary technology, the company produces targeted bacteria-killing phages in weeks to months, which complement and reduce the need for antibiotics. Applications span food safety, animal health (starting with poultry and swine), and human health, plus research on a phage nasal spray against SARS-CoV-2.

Read more

bacteriophage productionphage therapy researchvaccine research